Additive Effect of Twice Daily Brinzolamide 1%/Brimonidine 0.2% Fixed Dose Combination as an Adjunctive Therapy to a Prostaglandin Analogue
Phase of Trial: Phase IV
Latest Information Update: 17 May 2018
At a glance
- Drugs Brimonidine/brinzolamide (Primary) ; Bimatoprost; Latanoprost; Travoprost
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Alcon
- 28 Feb 2018 Status changed from active, no longer recruiting to completed.
- 03 Jan 2018 Planned End Date changed from 22 Feb 2018 to 1 Feb 2018.
- 03 Jan 2018 Planned primary completion date changed from 22 Feb 2018 to 1 Feb 2018.